Xact Kapitalforvaltning AB raised its stake in Gilead Sciences, Inc. (NASDAQ:GILD) by 4.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 261,826 shares of the biopharmaceutical company’s stock after buying an additional 11,835 shares during the quarter. Xact Kapitalforvaltning AB’s holdings in Gilead Sciences were worth $19,739,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business.....More>>>